Eva Frigola-Capell

Dr. Eva Frigola-Capell

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Revista Clínica Española
Verified
Journal Article
Closed access
EFEva Frigola-Capell
Eva Frigola-Capell
JCJosep Comín-Colet
Josep Comín-Colet
JDJ. Davins-Miralles
J. Davins-Miralles
IGIgnasi Gich
Ignasi Gich
MWMichel Wensing
Michel Wensing
JVJosé María Verdú-Rotellar
José María Verdú-Rotellar

28 June 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
GCGiulio Corrivetti
Giulio Corrivetti
FMFrancesco Monaco
Francesco Monaco
AVAnnarita Vignapiano
Annarita Vignapiano
AMAlessandra Marenna
Alessandra Marenna
KPKaia Palm
Kaia Palm
Alessio FasanoAlessio Fasano
Alessio Fasano
According to the World Health Organization (WHO), major depressive disorder (MDD) is the fourth leading cause of disability worldwide and the second most common disease after cardiovascular events. Approximately 280 million people live with MDD, with incidence varying by age and gender (female to male ratio of approximately 2:1). Although a variety of antidepressants are available for the different forms of MDD, there is still a high degree of individual variability in response and tolerability. Given the complexity and clinical heterogeneity of these disorders, a shift from “canonical treatment” to personalized medicine with improved patient stratification is needed. OPADE is a non-profit study that researches biomarkers in MDD to tailor personalized drug treatments, integrating genetics, epigenetics, microbiome, immune response, and clinical data for analysis. A total of 350 patients between 14 and 50 years will be recruited in 6 Countries (Italy, Colombia, Spain, The Netherlands, Turkey) for 24 months. Real-time electroencephalogram (EEG) and patient cognitive assessment will be correlated with biological sample analysis. A patient empowerment tool will be deployed to ensure patient commitment and to translate patient stories into data. The resulting data will be used to train the artificial intelligence/machine learning (AI/ML) predictive tool.

5 October 2012 in BMC Family Practice
Verified
Journal Article
Open access
PDF file
JLJan van Lieshout
Jan van Lieshout
RGRichard Grol
Richard Grol
SCStephen Campbell
Stephen Campbell
HFHector Falcoff
Hector Falcoff
EFEva Frigola-Capell
Eva Frigola-Capell
MWMichel Wensing
Michel Wensing
Primary care has an important role in cardiovascular risk management (CVRM) and a minimum size of scale of primary care practices may be needed for efficient delivery of CVRM . We examined CVRM in patients with coronary heart disease (CHD) in primary care and explored the impact of practice size. In an observational study in 8 countries we sampled CHD patients in primary care practices and collected data from electronic patient records. Practice samples were stratified according to practice size and urbanisation; patients were selected using coded diagnoses when available. CVRM was measured on the basis of internationally validated quality indicators. In the analyses practice size was defined in terms of number of patients registered of visiting the practice. We performed multilevel regression analyses controlling for patient age and sex. We included 181 practices (63% of the number targeted). Two countries included a convenience sample of practices. Data from 2960 CHD patients were available. Some countries used methods supplemental to coded diagnoses or other inclusion methods introducing potential inclusion bias. We found substantial variation on all CVRM indicators across practices and countries. We computed aggregated practice scores as percentage of patients with a positive outcome. Rates of risk factor recording varied from 55% for physical activity as the mean practice score across all practices (sd 32%) to 94% (sd 10%) for blood pressure. Rates for reaching treatment targets for systolic blood pressure, diastolic blood pressure and LDL cholesterol were 46% (sd 21%), 86% (sd 12%) and 48% (sd 22%) respectively. Rates for providing recommended cholesterol lowering and antiplatelet drugs were around 80%, and 70% received influenza vaccination. Practice size was not associated to indicator scores with one exception: in Slovenia larger practices performed better. Variation was more related to differences between practices than between countries. CVRM measured by quality indicators showed wide variation within and between countries and possibly leaves room for improvement in all countries involved. Few associations of performance scores with practice size were found.

5 April 2017 in European Journal of General Practice
Verified
Journal Article
Open access
JVJosé María Verdú-Rotellar
José María Verdú-Rotellar
EFEva Frigola-Capell
Eva Frigola-Capell
RARosa Alvarez-Pérez
Rosa Alvarez-Pérez
DSDaniela da Silva
Daniela da Silva
CECristina Enjuanes
Cristina Enjuanes
MMMiguel-Angel Muñoz
Miguel-Angel Muñoz
Background: Heart failure (HF) diagnosis as reported in primary care medical records is not always properly confirmed and could result in over-registration. Objectives: To determine the proportion of registered HF that can be confirmed with information from primary care medical records and to analyse related factors. Methods: A cross-sectional study. The medical records of 595 HF patients attended in two primary healthcare centres in Barcelona (Spain) were revised and validated by a team of experts who classified diagnosis into confirmed, unconfirmed, and misdiagnosis. Variables potentially related to the confirmation of the diagnosis were analysed. The revision of medical records and data collection took place from 15 January to 31 March 2014. Results: Mean (standard deviation) age was 78 (10) years and 58% were women. The diagnosis could be confirmed in 53.6% of patients. Factors associated with a greater probability of having a confirmed diagnosis were age (yearly OR: 0.97, 95%CI: 0.95–0.99), cardiologist follow-up (OR: 3.66, 95%CI: 2.46–5.48), history of ischaemic heart disease (OR: 2.18, 95%CI: 1.36–2.48), atrial fibrillation (OR: 2.01, 95%CI: 1.34–3.03), and prescription of loop diuretics (OR: 3.24, 95%CI: 2.14–4.89). Conclusion: Only in half of the patients labelled as HF in primary care medical records could this diagnosis be further confirmed. Variables regularly registered in clinical practice could help general practitioners identify those patients requiring a revision of their HF diagnosis.

28 May 2013 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
EFEva Frigola-Capell
Eva Frigola-Capell
JCJosep Comin-Colet
Josep Comin-Colet
JDJosep Davins-Miralles
Josep Davins-Miralles
IGIgnasi Gich
Ignasi Gich
MWMichel Wensing
Michel Wensing
JVJosé María Verdú-Rotellar
José María Verdú-Rotellar

14 August 2015 in European Journal of General Practice
Verified
Journal Article
Open access
EFEva Frigola-Capell
Eva Frigola-Capell
CPClara Pareja-Rossell
Clara Pareja-Rossell
MGMontse Gens-Barber
Montse Gens-Barber
GOGlòria Oliva-Oliva
Glòria Oliva-Oliva
FAFernando Alava-Cano
Fernando Alava-Cano
JDJosep Davins-Miralles
Josep Davins-Miralles
Background: Quality indicators are measured aspects of healthcare, reflecting the performance of a healthcare provider or healthcare system. They have a crucial role in programmes to assess and improve healthcare. Many performance measures for primary care have been developed. Only the Catalan model for patient safety in primary care identifies key domains of patient safety in primary care.